BR112016025036A2 - suspensões farmacêuticas líquidas contendo bismuto - Google Patents
suspensões farmacêuticas líquidas contendo bismutoInfo
- Publication number
- BR112016025036A2 BR112016025036A2 BR112016025036A BR112016025036A BR112016025036A2 BR 112016025036 A2 BR112016025036 A2 BR 112016025036A2 BR 112016025036 A BR112016025036 A BR 112016025036A BR 112016025036 A BR112016025036 A BR 112016025036A BR 112016025036 A2 BR112016025036 A2 BR 112016025036A2
- Authority
- BR
- Brazil
- Prior art keywords
- bismuth
- liquid pharmaceutical
- containing liquid
- pharmaceutical suspensions
- suspension system
- Prior art date
Links
- 229910052797 bismuth Inorganic materials 0.000 title abstract 2
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 title abstract 2
- 239000007788 liquid Substances 0.000 title abstract 2
- 239000007971 pharmaceutical suspension Substances 0.000 title abstract 2
- 239000000725 suspension Substances 0.000 abstract 2
- 229920002148 Gellan gum Polymers 0.000 abstract 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 abstract 1
- 235000010492 gellan gum Nutrition 0.000 abstract 1
- 239000000216 gellan gum Substances 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/29—Antimony or bismuth compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Physiology (AREA)
- Dispersion Chemistry (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
a presente invenção refere-se a uma suspensão farmacêutica líquida para administração oral que contém um agente farmacêutico contendo bismuto, um sistema de suspensão e água. o sistema de suspensão pode conter de cerca de 0,001% a cerca de 0,2% de goma gelana e de cerca de 0,001% a cerca de 0,75% de silicato de magnésio e alumínio.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461985650P | 2014-04-29 | 2014-04-29 | |
US61/985,650 | 2014-04-29 | ||
PCT/US2015/028216 WO2015168242A1 (en) | 2014-04-29 | 2015-04-29 | Bismuth-containing liquid pharmaceutical suspensions |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112016025036A2 true BR112016025036A2 (pt) | 2017-08-15 |
BR112016025036B1 BR112016025036B1 (pt) | 2023-09-05 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
US20150306113A1 (en) | 2015-10-29 |
US20180303947A1 (en) | 2018-10-25 |
PL3137056T3 (pl) | 2021-05-04 |
EP3137056A1 (en) | 2017-03-08 |
EP3137056B1 (en) | 2020-12-02 |
US10039835B2 (en) | 2018-08-07 |
US9486460B2 (en) | 2016-11-08 |
AU2015253188A1 (en) | 2016-10-06 |
WO2015168242A1 (en) | 2015-11-05 |
CN106456540A (zh) | 2017-02-22 |
CA2943422A1 (en) | 2015-11-05 |
CN106456540B (zh) | 2020-02-21 |
US20170021027A1 (en) | 2017-01-26 |
RU2676261C2 (ru) | 2018-12-27 |
AU2015253188B2 (en) | 2017-09-28 |
CA2943422C (en) | 2020-03-10 |
RU2016138028A (ru) | 2018-05-29 |
RU2016138028A3 (pt) | 2018-05-29 |
US10632200B2 (en) | 2020-04-28 |
MX2016013886A (es) | 2017-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016003263A1 (es) | Composiciones enriquecidas esteroquímicamente para la liberación de ácidos nucléicos. | |
EP3398948A3 (en) | 2,4,6,7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof | |
DK3328843T3 (da) | 1,3,4-oxadiazolsulfonamidderivat-forbindelser som histon- deacetylase-6-inhibitor, og den farmaceutske sammensætning | |
CL2015002529A1 (es) | Compuestos de tetrahidropirrolotiazina | |
PL3785733T3 (pl) | Kompozycja farmaceutyczna do leczenia autyzmu | |
BR112017010311A2 (pt) | 4-oxo-3,4-dihidro-1,2,3-benzotriazinas como moduladores de gpr139 | |
UY36178A (es) | Novedosos derivados de ácido heteroaril-butanoico | |
MA54716A (fr) | Réduction de la viscosité de formulations pharmaceutiques | |
MX2016013886A (es) | Suspensiones farmaceuticas liquidas que contienen bismuto. | |
CL2017000230A1 (es) | Composición adhesiva | |
CL2016000148A1 (es) | Nuevos compuestos isoindolina o isoquinolina, un proceso para su preparación y composiciones farmacéuticas que los contienen. | |
MA40781A (fr) | Composition pharmaceutique d'isotrétinoïne à faible dosage destinée à la voie orale | |
MX370908B (es) | Metodo para fabricar suspensiones farmaceuticas liquidas que contienen bismuto. | |
BR112016012838A2 (pt) | Composição para a administração oral de um agente bioativo incluindo partículas que compreendem um agente bioativo e um polímero mucoadesivo em uma solução aquosa, e, método de preparação da composição | |
CL2016001763A1 (es) | Antagonistas selectivos de nr2b | |
EP3626712A3 (en) | Liver x receptor (lxr) modulators | |
BR112015020307A2 (pt) | formulação de cápsula rígida | |
WO2014197536A3 (en) | Novel beta lactams as modulators of glutamate uptake and methods for use thereof | |
SV2017005417A (es) | Composición farmacéutica solida que comprende amlodipino y losartán | |
BR112015020038A2 (pt) | suspensão de proteína como um sistema opacificante de bebida | |
CL2017000988A1 (es) | Proceso de síntesis de hidroxi-triacilgliceroles y usos de los mismos para la prevención y el tratamiento de enfermedades | |
WO2016109361A3 (en) | 3-fluoro-benzonitrile inhibitors of 11-beta-hydroxylase | |
BR112014026879A2 (pt) | formulação oral, e, substrato | |
CL2016003219A1 (es) | Desmopresina estabilizada | |
ITUA20163606A1 (it) | Sistema ottico per la enfatizzazione 3d di effetti luminosi. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/04/2015, OBSERVADAS AS CONDICOES LEGAIS |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: REFERENTE A RPI 2748 DE 05/09/2023, QUANTO AO ITEM (72) NOME DO INVENTOR. |